Symbiance

Princeton, USA Founded: 1990 • Age: 36 yrs Acquired By ACL Digital
Symbiance is recognized as a technology-enabled Contract Research Organization.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 5 Services tracked
Competitors 10 Brand Intelligence

About Symbiance

Symbiance is a company based in Princeton, USA founded in 1990 was acquired by ACL Digital in September 2025. It operates as a Professional Services. Symbiance offers products and services including Clinical Data Management, Biostatistics, Pharmacovigilance, SAS Programming, and Clinical Data Standardization. Symbiance operates in a competitive market with competitors including Zifo RnD Solutions, Ephicacy, Syne Qua Non, Conexus and Panome Bio, among others.

  • Headquarter Princeton, USA
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    ACL Digital

    (Sep 26, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Symbiance

Symbiance offers a comprehensive portfolio of products and services, including Clinical Data Management, Biostatistics, Pharmacovigilance, SAS Programming, and Clinical Data Standardization.

Product name locked
Category locked
Primary

Data management services are provided for clinical trials.

Product name locked
Category locked
Locked

Statistical analysis is offered for clinical research studies.

Product name locked
Category locked
Locked

Drug safety monitoring is conducted for pharmaceutical clients.

Product name locked
Category locked
Locked

Programming support is provided for clinical data analysis.

Product name locked
Category locked
Locked

Data standardization services are delivered for clinical studies.

People of Symbiance

Headcount 200-500
Employee Profiles 5
Employee Profiles
People
Alphons Philips
Vice President, Pharmacovigilance And Regulatory Operations
People
Nate Harris
Director Of Business Development
People
Mark Pittman
Head Of Marketing & Inside Sales

Unlock access to complete

Funding Insights of Symbiance

Premium access

Detailed funding history for Symbiance

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Symbiance

Symbiance has secured backing from 1 investor. Prominent investors backing the company include ACL Digital.

All
Investor Description Founded Year Domain Location
ACL Digital is engaged in digital engineering and transformation services.
Locked Locked Locked
Premium access

Investor details for Symbiance

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Symbiance

Investments
Premium access

Investment portfolio details for Symbiance

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Symbiance

Premium access

Detailed financials for Symbiance

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Symbiance Comparisons

Symbiance Primary company
Description
Symbiance is recognized as a technology-enabled Contract Res...
Location
Princeton, USA
Founded Year
1990
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Symbiance

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Symbiance

Symbiance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zifo RnD Solutions, Ephicacy, Syne Qua Non, Conexus and Panome Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Clinical data management services are provided to biopharma sector.
Locked Locked Locked
Biostatistics and statistical programming services are provided for clinical development.
Locked Locked Locked
Major European functional service provider offering services for data management, EDC, and biostatistics
Locked Locked Locked
Natural gas transmission and storage services are provided in Latvia.
Locked Locked Locked
Clinical data analytics services are provided for healthcare applications.
Locked Locked Locked
Provider of diversified outsourcing services for pharmaceutical, biotech, and medical device companies
Premium access

Detailed competitors of Symbiance

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Symbiance

Premium access

Complete news archive for Symbiance

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Symbiance

Symbiance was founded in 1990.

Symbiance is established as a full-service Contract Research Organization (CRO) that leverages technology to provide innovative solutions for pharmaceutical, biotechnology, and medical device companies. Services such as clinical data management, biostatistics, SAS programming, pharmacovigilance, and clinical data standardization are offered. The focus is placed on delivering efficient and precise outcomes to support medical breakthroughs across various therapeutic areas. Advanced technologies like machine learning and analytics are integrated into the service model to enhance client outcomes in the healthcare sector.

Symbiance's top competitors include Zifo RnD Solutions, Conexus and Syne Qua Non.

Symbiance offers Clinical Data Management, Biostatistics, Pharmacovigilance, SAS Programming, and Clinical Data Standardization.

Symbiance has 1 investor. Key investors include ACL Digital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available